Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine-bombesin conjugate

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 7, 2008, Pages 2424-2427

  Dubuc, Céléna ^a   Langlois, Réjean ^a   Bénard, François ^a   Cauchon, Nicole ^a   Klarskov, Klaus ^a   Tone, Paul ^b   van Lier, Johan E ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b RICHMOND UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bombesin conjugate; Photodynamic therapy; Sulfonated phthalocyanines

Indexed keywords

CARBON 14; GASTRIN RELEASING PEPTIDE RECEPTOR; PHOTOSENSITIZING AGENT; PHTHALOCYANINE BOMBESIN CONJUGATE; PHTHALOCYANINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CANCER CELL; CONTROLLED STUDY; DRUG EFFICACY; GASTRIN RELEASE; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PHOTODYNAMIC THERAPY; PROSTATE CANCER;

EID: 41149088959     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.02.051     Document Type: Article

References (18)

1. Henderson B.W., and Dougherty T.J. Photochem. Photobiol. 55 (1992) 145
2. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., Moan J., and Peng Q. J. Natl. Cancer Inst. 90 (1988) 889
3. Sharman W.M., van Lier J.E., and Allen C.M. Adv. Drug Deliv. Rev. 56 (2004) 53
4. Hamblin M.R., Miller J.L., and Ortel B. Photochem. Photobiol. 72 (2000) 533
5. Allen C.M., Sharman W.M., and van Lier J.E. J. Porphyrines Phthalocyanines 5 (2001) 161
6. Brasseur N., Langlois R., La Madeleine C., Ouellet R., and van Lier J.E. Photochem. Photobiol. 69 (1999) 345
7. Carcenac M., Larroque C., Langlois R., van Lier J.E., Artus J.C., and Pelegrin A. Photochem. Photobiol. 70 (1999) 930
8. Moody T.W., Bertness V., and Carney V. Peptides 4 (1983) 683
9. Kris R.M., Hazan R., Villines J., Moody T.W., and Schlessinger J. J. Biol. Chem. 262 (1987) 11215
10. Yegen B.G. Curr. Pharm. Des. 9 (2003) 1013
11. Xiao D., Wang J., Hampton L.L., and Weber H.C. Gene 264 (2001) 95
12. Scheffel U., and Pomper M.G. J. Nucl. Med. 45 (2004) 1277
13. Hoffman T.J., Gali H., Smith C.J., Sieckman L.G., Hayes D.L., Owen N.K., and Volkert W.A. J. Nucl. Med. 44 (2003) 823
14. 1]-fibrinopeptide B (Oakville, ON, Canada).
15. d) and relative binding affinities (RBA: bombesin concentration required for 50% competition, divided by the competitor's concentration required for 50% competition, 100×).
16. Aprikian A.G., Han K., Chevalier S., Bazinet M., and Viallet J. J. Mol. Endocrinol. 16 (1996) 297
17. Reile H., Armatis P.E., and Schally A.V. Prostate 25 (1994) 29
18. 50) at a given light dose was extrapolated from survival curves.